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Aim
to evaluate the ability of the baculovirus-expressed HIV-
VLPA to induce the maturation and activation of mono-
cyte-derived dendritic cells (MDDCs).
Results
the VLP-activated MDDCs show an enhanced Th1 and
Th2-specific cytokine production and the effects of VLPs
on MDDCs are, to some extent, mediated through intra-
cellular Toll-like receptors signaling. The VLP-loaded
MDDCs are able to induce a primary and secondary
response in autologous T cells, using an in vitro immuni-
zation assay. Moreover, the genomic transcriptional pro-
file of VLP-activated DCs show, by gene microarray
analysis, the upregulation of several genes involved in the
immune response.
Conclusion
Our results show that baculovirus VLPs activate MDDCs
and may "cross" over to the endogenous pathway to gain
access to MHC class I, inducing CD8+ cytotoxic T cells
activation. The intra-cellular Toll-like receptors appear to
be involved in this process; additional signaling pathways
induced by VLPs in the MDDCs are currently under eval-
uation. These data give an insight into the mechanisms of
the cellular immunity induced in vivo by VLPs, which may
be extremely useful to optimize and modulate the
immune response.
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